BMS adds to diversity and inclusion programs

June 28, 2019 Latest News 'MyBioPharmaSpace'

This is a preview of subscriber content

Subscribe now to continue reading.

Bristol-Myers Squibb Australia has launched its latest 'Diversity and Inclusion' initiative with a special address delivered by former SBS World News Presenter, Lee Lin Chin. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 - Latest News
PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations
February 15, 2026 - Latest News
Rare Cancers Australia sets sights on 2026 Kosi Challenge with renewed fundraising momentum
February 15, 2026 - Latest News
New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial
February 16, 2026 - Australian Biotech
Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh
February 16, 2026 - Australian Biotech

BMS adds to diversity and inclusion programs

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Rare Cancers Australia sets sights on 2026 Kosi Challenge with renewed fundraising momentum

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh

New Stories

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'

Sign In

BMS adds to diversity and inclusion programs

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Rare Cancers Australia sets sights on 2026 Kosi Challenge with renewed fundraising momentum

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh

Follow Us

New Stories

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'